Next, we introduced ASH1L-F3 into LNCaP (a PCa cell line with low metastatic potential and low expression of ASH1L) and confirmed its histone methyltransferase activity at H3K36 and H3K4 (Fig. 1i). The gene discussed is PRDM9; the disease is posterior cortical atrophy.